Characterization and clinical management of abnormal cytology findings in pregnant women: a retrospective analysis.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
12 2022
Historique:
received: 27 05 2022
accepted: 03 07 2022
pubmed: 18 8 2022
medline: 8 11 2022
entrez: 17 8 2022
Statut: ppublish

Résumé

The diagnosis of cervical intraepithelial neoplasia during pregnancy poses a great challenge to the treating clinician and the patient. According to the current guidelines, watchful waiting during pregnancy can be justified. Only in cases of invasion, immediate treatment may be indicated. However, few data are available on the management of cervical dysplasia during pregnancy. Further research is important for counselling affected women. Data of pregnant patients with suspected cervical dysplasia who presented to the University Women's Hospital Tübingen between 2008 and 2018 were evaluated retrospectively. Colposcopic, cytologic, and histologic assessment was performed for diagnosis. Data on remission, persistence and progression of disease based on histologic and cytologic assessment and the mode of delivery were correlated. 142 patients were enrolled. Cytology at first presentation was PAPIII (-p/-g) in 7.0%, PAPIIID (IIID1/IIID2) in 38.7%, PAPIVa (-p/-g) in 50.0%, PAPIVb (-p) in 2.8%, and PAPV (-p) in 1.4%. All cases with suspected invasion were recorded at the initial presentation. Complete histological or cytological remission was observed in 24.4%, partial remission in 10.4%, persistence in 56.3%, and progression in 8.9%. In two cases (1.5%) progression to squamous cell carcinoma occurred. Watchful waiting for cervical intraepithelial neoplasia during pregnancy seems to be sufficient and oncologically safe. It is important to exclude invasion during pregnancy, to perform frequent colposcopic, cytologic and histologic examinations and to ensure a postpartum follow-up examination to initiate the treatment of high-grade lesions. Spontaneous delivery seems to be safe in patients with cervical dysplasia, Caesarean section is not indicated.

Identifiants

pubmed: 35976386
doi: 10.1007/s00404-022-06699-7
pii: 10.1007/s00404-022-06699-7
pmc: PMC9633466
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2017-2026

Informations de copyright

© 2022. The Author(s).

Références

Anticancer Res. 2013 Feb;33(2):711-5
pubmed: 23393372
Gynecol Oncol. 1996 Jan;60(1):30-4
pubmed: 8557224
Lancet. 2012 Feb 11;379(9815):558-69
pubmed: 22325661
Acta Obstet Gynecol Scand. 2000 Apr;79(4):306-10
pubmed: 10746847
Fukushima J Med Sci. 2002 Jun;48(1):27-37
pubmed: 12365596
Virology. 1991 Sep;184(1):9-13
pubmed: 1651607
Gynecol Oncol. 2013 Feb;128(2):282-7
pubmed: 23088926
Am J Obstet Gynecol. 2004 Jul;191(1):105-13
pubmed: 15295350
Gynecol Obstet Invest. 2002;54(2):78-81
pubmed: 12566748
Diagn Cytopathol. 1997 Aug;17(2):99-107
pubmed: 9258616
Vaccine. 2012 Nov 20;30 Suppl 5:F55-70
pubmed: 23199966
Int J Gynecol Cancer. 2018 May;28(4):641-655
pubmed: 29688967
Expert Rev Anticancer Ther. 2013 Jan;13(1):29-42
pubmed: 23259425
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482
Obstet Gynecol. 1999 Mar;93(3):359-62
pubmed: 10074979
Int J Gynecol Pathol. 1993 Apr;12(2):186-92
pubmed: 8463044
Br J Cancer. 2004 Aug 31;91(5):942-53
pubmed: 15292939
Obstet Gynecol. 1993 Jun;81(6):915-8
pubmed: 8497355
J Clin Med. 2021 Nov 15;10(22):
pubmed: 34830596
Eur Rev Med Pharmacol Sci. 2014;18(6):851-60
pubmed: 24706310
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
Eur J Obstet Gynecol Reprod Biol. 2019 May;236:173-176
pubmed: 30933887
Acta Cytol. 1997 Mar-Apr;41(2):269-76
pubmed: 9100753
Eur J Obstet Gynecol Reprod Biol. 2002 Aug 5;104(1):67-9
pubmed: 12128266
Cancer. 2004 Aug 25;102(4):228-32
pubmed: 15368314
Am J Obstet Gynecol. 1998 Jun;178(6):1116-20
pubmed: 9662288
Am J Obstet Gynecol. 2010 Aug;203(2):113.e1-6
pubmed: 20522409
Sao Paulo Med J. 2009 Nov;127(6):359-65
pubmed: 20512291
Arch Gynecol Obstet. 2013 Feb;287(2):245-50
pubmed: 23053308
Acta Obstet Gynecol Scand. 2008;87(12):1296-300
pubmed: 18951206
Am J Obstet Gynecol. 2005 May;192(5):1452-4
pubmed: 15902135
Eur J Obstet Gynecol Reprod Biol. 1995 Sep;62(1):31-6
pubmed: 7493705
Int J Gynaecol Obstet. 2019 Apr;145(1):129-135
pubmed: 30656645

Auteurs

Rosa Freudenreich (R)

Department of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany.
Eberhard Karls University of Tübingen, Tübingen, Germany.

Martin Weiss (M)

Department of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany.

Tobias Engler (T)

Department of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany.

Felix Neis (F)

Department of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany.

Melanie Henes (M)

Department of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany. melanie.henes@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH